排卵与着床期镇痛药使用与人类生育力的关联
该前瞻性队列研究纳入30至44岁自然备孕女性,分析2008至2015年数据,评估排卵前、围排卵期、着床期及全周期使用对乙酰氨基酚、阿司匹林或非阿司匹林非甾体抗炎药与受孕概率的关联。结果显示非阿司匹林非甾体抗炎药和对乙酰氨基酚各时间窗均无关联,着床期阿司匹林使用与受孕概率升高相关(校正受孕率比2.05,95%CI 1.23-3.41)。
要点
- 着床期阿司匹林使用与受孕概率升高相关,校正受孕率比2.05(95%CI 1.23-3.41)。
- 非阿司匹林非甾体抗炎药和对乙酰氨基酚在各时间窗均与受孕概率无关联。
- 作者认为着床期可能是阿司匹林影响受孕的重要靶点,结论需临床试验验证。
核心结论
- 着床期阿司匹林使用与受孕概率升高相关,该结果扩展了既往文献,提示着床期可能是阿司匹林影响受孕的重要靶点,且阿司匹林可能有益 regardless of pregnancy loss history,这些观察需临床试验验证。
研究设计与样本
- 前瞻性队列研究,纳入2008至2015年30至44岁自然备孕女性,共858名女性、2366个月经周期,使用每日日记记录药物使用,采用离散时间受孕概率模型估计校正受孕率比及95%置信区间。
主要发现
- 非阿司匹林非甾体抗炎药或对乙酰氨基酚的使用在排卵前、围排卵期、着床期及全周期各时间窗均与受孕概率无关联。
- 着床期阿司匹林使用与受孕概率升高相关,校正受孕率比2.05(95%CI 1.23-3.41),该关联在限制缺失数据最少的周期或校正孕次后仍存在。
- 其他药物均与受孕概率无关联。
关键数值与推荐
- 着床期阿司匹林使用校正受孕率比2.05(95%CI 1.23-3.41),样本量小。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出样本量小。
- 原文结论指出这些观察需临床试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies investigating the effects of pain-relieving medication use on conceiving a pregnancy have shown conflicting results. Furthermore, no previous study has examined medication use around ovulation or implantation and the associations with the probability of conception, fecundability. OBJECTIVE: The objective of the study was to explore the association between fecundability and analgesic use in 3 different menstrual cycle windows (preovulation, periovulation, and implantation) as well as across the entire menstrual cycle. STUDY DESIGN: We analyzed data from a prospective cohort study of women between 30 and 44 years of age who were trying to conceive naturally from 2008 through 2015. Using daily diaries, medication usage was classified as acetaminophen, aspirin, or nonaspirin nonsteroidal antiinflammatory drug during 4 time periods of interest (preovulatory, periovulatory, and implantation) as well as the overall nonmenstrual bleeding days of the cycle. Menstrual cycles during the prospective attempt to become pregnant were enumerated using daily diary menstrual bleeding information. Conception was defined as a positive home pregnancy test. Discrete time fecundability models were used to estimate the fecundability ratio and 95% confidence interval in each of the 4 time windows of interest and for each pain reliever (aspirin use, nonaspirin nonsteroidal antiinflammatory drug use, acetaminophen) compared with no medication use after adjustment for several covariates including age, race, education, body mass index, alcohol and caffeine use, frequency of intercourse, and a history of migraines or uterine fibroids. RESULTS: Medication use was infrequent in the 858 women and 2366 cycles in this analysis. Use of nonaspirin nonsteroidal antiinflammatory drugs or acetaminophen was not associated with fecundability in any of the time windows of interest. Although the sample size was small, aspirin use during the implantation window was associated with increased fecundability (adjusted fecundability ratio [confidence interval]: 2.05 [1.23-3.41]). This association remained when limiting the analysis to cycles with minimal missing data or when adjusting for gravidity. None of the other medications were associated with fecundability. CONCLUSION: Aspirin use around implantation was associated with increased fecundability. These results expand previous literature to suggest the following: (1) implantation may be an important target for the effects of aspirin on conception and (2) aspirin may be beneficial, regardless of pregnancy loss history. These observations should be tested with a clinical trial.
引用
- Jukic AMZ, Padiyara P, Bracken MB, et al. Analgesic use at ovulation and implantation and human fertility. Am J Obstet Gynecol. 2019. PMID: 31738897. doi:10.1016/j.ajog.2019.11.1251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。